End-tidal carbon dioxide and amplitude spectral area as non-invasive markers of coronary perfusion pressure
End-tidal carbon dioxide (ETCO 2 ) measurements may be used alone as a guide to determine when to defibrillate an individual. Alternatively, ETCO 2 measurements may be used in combination with amplitude spectral area measurements as a guide to determine when to defibrillate an individual.
1. A defibrillation device for guiding defibrillation therapy of an individual during resuscitation, comprising:
an end-tidal carbon dioxide (ETCO 2 ) sensor for obtaining signals representing ETCO 2 of the individual;
an electrocardiogram (ECG) sensor for obtaining signals representing ECG of the individual; and
a processor in communication with the ETCO 2 sensor and the ECG sensor and configured to:
receive and process the signals representing ETCO 2 from the ETCO 2 sensor to generate ETCO 2 data,
receive and process the signals representing ECG from the ECG sensor to generate ECG data,
analyze the ETCO 2 data and the ECG data, the analysis of the ECG data being frequency-based,
determine, based on the analysis of the ETCO 2 data and the ECG data, whether a defibrillation shock should be delivered to the individual, and
provide an indication that designates whether the defibrillation shock should be delivered.
2. The device of claim 1 , wherein the determination is based on whether the ETCO 2 data is higher or lower than a first predetermined threshold value.
3. The device of claim 2 , wherein the predetermined threshold value is from 5 mmHg to 20 mmHg.
4. The device of claim 1 , wherein the processor is configured to perform a frequency domain transform on the ECG data.
5. The device of claim 4 , wherein the frequency domain transform results in an amplitude spectrum area (AMSA) value.
6. The device of claim 5 , wherein the determination is further based on whether the AMSA value is higher or lower than a second predetermined threshold value.
7. The device of claim 6 , wherein the second predetermined threshold value is from 31 mV-Hz to 45 mV-Hz.
8. The device of claim 1 , wherein the determination is based on analysis of both the ECG data and the ETCO 2 data.
9. The device of claim 8 , wherein the determination is based on a comparison of the ECG data to a first predetermined threshold and a comparison of the ETCO 2 data to a second predetermined threshold value.
10. The device of claim 1 , further comprising a display, and wherein the processor is configured to provide the indication of whether the defibrillation shock should be delivered on the display.
11. The device of claim 10 , wherein the indication comprises a prompt on the display instructing a user as to the proper time to deliver the defibrillating shock.
12. The device of claim 1 , further comprising one or more speakers for providing the indication of whether the defibrillation shock should be delivered.
13. The device of claim 12 , wherein the indication comprises a prompt instructing a user as to a proper time to deliver the defibrillating shock.
14. The device of claim 1 , further comprising a defibrillator.
15. The device of claim 14 , further comprising further comprising defibrillation electrodes.
16. The device of claim 14 , wherein the processor is configured to instruct the defibrillator to provide the defibrillating shock based on the determination.
17. The device of claim 1 , further comprising one or more additional sensors.
18. The device of claim 17 , wherein the one or more additional sensors are one or more of a heart rate sensor, a blood pressure sensor, a temperature sensor, a bispectral index sensor, an oxygen sensor, a blood lactate sensor, a blood pH sensor, a tissue lactate sensor, a tissue pH sensor, an intracardiac pressure sensor, an intrathoracic pressure sensor, a positive end expiratory pressure sensor, a respiratory rate sensor, an intracranial pressure sensor, an intraocular pressure sensor, a respiratory flow sensor, an oxygen delivery sensor, a tissue CO 2 sensor, and a cardiac output sensor.
19. The device of claim 1 , wherein the processor is in communication with one or more circulation enhancement devices.
20. The device of claim 19 , wherein the circulation enhancement device is configured to generate a negative intrathoracic pressure within a patient.